JONATHAN LEWIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN LEWIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN LEWIS. JONATHAN LEWIS is CEO in ZIOPHARM ONCOLOGY INC ($ZIOP).
Latest Insider Trading Transactions of JONATHAN LEWIS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 11 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 5.14 | 15,190 | 78,077 | 479,510 | 494.7 K to 479.5 K (-3.07 %) |
Jan 03 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | D | 4.77 | 150,000 | 715,500 | 150,000 | |
Jan 03 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 4.77 | 21,475 | 102,436 | 494,700 | 516.2 K to 494.7 K (-4.16 %) |
Sep 24 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 3.95 | 128,850 | 508,958 | 516,175 | 645 K to 516.2 K (-19.98 %) |
Jan 12 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 3.10 | 12,650 | 39,215 | 645,025 | 657.7 K to 645 K (-1.92 %) |
Jan 05 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 2.85 | 150,000 | 427,500 | 150,000 | |
Jan 05 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Grant | A | 0.00 | 150,000 | 0 | 657,675 | 507.7 K to 657.7 K (+29.55 %) |
Dec 07 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 3.66 | 47,625 | 174,308 | 507,375 | 555 K to 507.4 K (-8.58 %) |
Sep 24 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Grant | A | 0.00 | 300,000 | 0 | 555,000 | 255 K to 555 K (+117.65 %) |
May 15 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 0.70 | 100,000 | 70,000 | 100,000 | |
Dec 05 2008 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Grant | A | 0.83 | 150,000 | 124,500 | 255,000 | 105 K to 255 K (+142.86 %) |
Jan 23 2008 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Grant | A | 0.00 | 100,000 | 0 | 105,000 | 5 K to 105 K (+2,000.00 %) |
Dec 17 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 2.73 | 100,000 | 273,000 | 100,000 | |
Dec 10 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Buy | P | 3.00 | 3,000 | 8,990 | 5,000 | 2 K to 5 K (+150.00 %) |
Jun 19 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 4.85 | 35,000 | 169,750 | 35,000 | |
Mar 14 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Buy | P | 4.95 | 2,000 | 9,900 | 2,000 | 0 to 2 K |
Jan 22 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 6.49 | 30,000 | 194,700 | 30,000 | |
Apr 27 2006 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 5.01 | 75,000 | 375,750 | 75,000 | |
Apr 27 2006 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 5.01 | 139,315 | 697,968 | 139,315 | |
Sep 15 2005 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | J | 0.08 | 54,161 | 4,333 | 54,161 | |
Sep 15 2005 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | J | 0.08 | 87,789 | 7,023 | 87,789 | |
Sep 15 2005 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | J | 0.08 | 242,979 | 19,438 | 242,979 | |
Sep 15 2005 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | J | 0.08 | 25,674 | 2,054 | 25,674 |
Page: 1